Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
"Lysosomal glycogen storage disease with normal acid maltase" which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Whole‐body deletion of Lamp2 | Accelerated development of a vacuolar cardioskeletal myopathy similar to Danon disease | Nishino et al (2000), Tanaka et al (2000) |”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al (2000)
In the citing paper
“In addition, broad‐spectrum autophagic defects tied to the systemic ablation of LAMP2 (causing Danon disease) account for the early development of hypertrophic cardiomyopathy (Nishino et al, 2000; Tanaka et al, 2000).”
From Autophagy in major human diseases (2021) · cites this paper as Nishino et al, 2000
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor‐Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o · Cited by 1,025
Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice
Tanaka, Y., Guhde, G., Suter, A., Eskelinen, E.-L., Hartmann, D., Lüllmann-Rauch, R., Janssen, P. M. L., Blanz, J., von Figura, K., & Saftig, P. (2000) · Nature · doi:10.1038/35022595 · Cited by 925 · cited 1×
“From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon diseas”
ResultA novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis
Town, M., Jean, G., Cherqui, S., Attard, M., Forestier, L., Whitmore, S. A., Callen, D. F., Gribouval, O., Broyer, M., Bates, G. P., et al. (1998) · Nature Genetics · doi:10.1038/ng0498-319 · Cited by 639 · cited 1×
“Our results, together with the recent identification of mutations in the lysosomal proteins cystinosin and sialin that cause nephropathic cystinosi”
ResultLysosomal glycogen storage disease with normal acid maltase
Danon, M. J., Oh, S. J., DiMauro, S., Manaligod, J. R., Eastwood, A., Naidu, S., & Schliselfeld, L. H. (1981) · Neurology · doi:10.1212/wnl.31.1.51 · Cited by 405 · cited 4×
“In 1981, Danon et al.1 reported two boys with the clinical triad of cardiomyopathy, myopathy and mental retardation.”
BackgroundInfluentialSelf-citationSaitoh, O., Wang, W. C., Lotan, R., & Fukuda, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42823-2 · Cited by 308
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases
Verheijen, F. W., Verbeek, E., Aula, N., Beerens, C. E. M. T., Havelaar, A. C., Joosse, M., Peltonen, L., Aula, P., Galjaard, H., van der Spek, P. J., et al. (1999) · Nature Genetics · doi:10.1038/70585 · Cited by 293
Lysosomes, a meeting point of proteins, chaperones, and proteases
Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 201 · cited 1×
“Alternatively, the unusual muscle pathology in DD might result from impaired lysosomal protein processing because the cytoplasmic tail of LAMP-2 functions as a receptor for the uptake of certain proteins into lysosome in association with the relative molecular mass ( M r ) 73,000 heat shock cognate protei”
BackgroundPattern of malformations in the axial skeleton in human triploid fetuses
Kjær, I., Keeling, J. W., Smith, N. M., & Hansen, B. F. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19971017)72:2<135::aid-ajmg3>3.0.co;2-u · Cited by 120
Konecki, D. S., Foetisch, K., Zimmer, K.-P., Schlotter, M., & Konecki, U. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2528 · Cited by 116 · cited 1×
“Human exon 9 exists in two forms, 9a and 9b, which are alternatively spliced and produce two isoforms, LAMP-2a and LAMP-2b, respectivel”
Background
Research works printed but not linked: 1
- Lewin, B. Genes VI (Oxford Univ. Press, Oxford, 1997).
Cited by
Items 601–700 of 1,000
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy
Yadin, D., Guetta, T., Petrover, Z., Alcalai, R., Seidman, J. G., Seidman, C. E., Ofek, E., Kornowski, R., Hochhauser, E., & Arad, M. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115735 · Cited by 14
History and Perspective of LAMP-2 Deficiency (Danon Disease)
Sugie, K., & Nishino, I. (2024) · Biomolecules · doi:10.3390/biom14101272 · Cited by 14
“In 2000, Nishino et al. revealed a primary deficiency of LAMP-2 caused by a mutation in lysosome-associated membrane protein type 2 ( LAMP2 ) [2].”
BackgroundSelf-citationStudying the pathophysiologic connection between cardiovascular and nervous systems using stem cells
Coskun, V., & Lombardo, D. M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23924 · Cited by 14
“Mutations in the lysosome-associated membrane protein 2 (LAMP-2)— leading to deficiency of the LAMP-2 protein—are the underlying reason for Danon disease (Nishino et al., 2000).”
BackgroundProgrammable hybridization assemble nicked displacement amplification for detecting ricin toxin
Wang, Y., Peng, Y., Bai, J., Li, S., Han, D., Ren, S., Qin, K., Li, S., Han, T., Zhou, H., et al. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132139 · Cited by 14
Sanchez, A. M. J., Candau, R. B., Raibon, A., & Bernardi, H. (2015) · InTech eBooks · doi:10.5772/60698 · Cited by 14
Danon disease: a case report and literature review
Xu, J., Zhu, L., Liu, Y., Zhang, X., Niu, F., Zheng, H., Wang, L. Y., Kang, L., Wang, K., & Xu, B. (2021) · Diagnostic Pathology · doi:10.1186/s13000-021-01100-8 · Cited by 14
“later onset and slower progression of the disease [2, 13].”
BackgroundLAMP-2 deficiency (Danon disease).
Mauro, S. D., Tanji, K., & Hirano, M. (2007) · Europe PMC (PubMed Central) · Cited by 14
Self-citationDanon disease due to a novel splice mutation in the LAMP2 gene
Nadeau, A., Therrien, C., Karpati, G., & Sinnreich, M. (2007) · Muscle & Nerve · doi:10.1002/mus.20930 · Cited by 15
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease
Marino, M., Musumeci, O., Paleologo, G., Cucinotta, M. D., Migliorato, A., Rodolico, C., & Toscano, A. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.09.025 · Cited by 14
Wang, S., Wang, J., Yang, L., Guo, R., Huang, E., Yang, H., Zhang, Y., Sun, L., Song, R., Chen, J., et al. (2019) · Biochimie · doi:10.1016/j.biochi.2019.07.018 · Cited by 14
Knecht, E., & Salvador-Montoliu, N. (2007) · Springer eBooks · doi:10.1007/0-387-28957-7_15 · Cited by 14
The multifaceted role of autophagy and mitophagy in cardiovascular health and disease
Nàger, M., Calvoli, M., Larsen, K. B., & Birgisdottir, Å. B. (2025) · Autophagy Reports · doi:10.1080/27694127.2025.2572511 · Cited by 14
“Mutations in the LAMP2 gene in humans are associated with Danon disease which presents symptoms such as hypertrophic or dilated cardiomyopathy, heart failure, muscle weakness, retinopathy, and cognitive impairment [90] .”
Barndt, R. J., Liu, Q., Tang, Y. M., Haugh, M. P., Cui, J., Chan, S. Y., & Wu, H. (2022) · Biomolecules · doi:10.3390/biom13010069 · Cited by 13
“The underlying mechanism of arrhythmogenesis of DD has not been clarified in previous modeling studies [12,17,18].”
BackgroundImplantation of a Left Ventricular Assist Device for Danon Cardiomyopathy
Kitahara, H., Nawata, K., Kinoshita, O., Itoda, Y., Shintani‐Domoto, Y., Fukayama, M., & Ōno, M. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.07.022 · Cited by 13
The lysosomal membrane protein LAMP‐2 is dispensable for PINK1/Parkin‐mediated mitophagy
Liu, X., Liao, X., Rao, X., Wang, B., Zhang, J., Xu, G., Jiang, X., Qin, X., Chen, C., & Zou, Z. (2019) · FEBS Letters · doi:10.1002/1873-3468.13663 · Cited by 13
Ameri, P., Schiattarella, G. G., Crotti, L., Torchio, M., Bertero, E., Rodolico, D., Forte, M., Mauro, V. D., Paolillo, R., Chimenti, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041192 · Cited by 13
Danon Disease Due to a Novel LAMP2 Microduplication
Lines, M. A., Hewson, S., HALLIDAY, W. C., Sabatini, P. J. B., Stockley, T. L., Dipchand, A. I., Bowdin, S. C., & Siriwardena, K. (2013) · JIMD Reports · doi:10.1007/8904_2013_277 · Cited by 13
A review of treatment of Pompe disease in infants.
Chien, Y., & Hwu, W. (2007) · PubMed Central · Cited by 13
Wu, G., Huang, J. A., Wei, G., Liu, L., Pang, S., & Yan, B. (2011) · Clinical Cardiology · doi:10.1002/clc.20870 · Cited by 13
Unique Aspects of Hypertrophic Cardiomyopathy in Children
Townsend, M., Jeewa, A., Khoury, M., Cunningham, C., George, K., & Conway, J. L. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.01.013 · Cited by 12
Heart transplantation in two adolescents with Danon disease
Oren, D., Chau, P., Manning, M. A., Kwong, J., Kaufman, B. D., Maeda, K., Rosenthal, D. N., & Hollander, S. A. (2018) · Pediatric Transplantation · doi:10.1111/petr.13335 · Cited by 12
A Clinical Approach to a Family History of Sudden Death
Tan, B. Y., & Judge, D. P. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.959437 · Cited by 12
Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies
Asatryan, B., & Medeiros‐Domingo, A. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1685-y · Cited by 12
Autophagy: a target for therapeutic interventions in myocardial pathophysiology
Halapas, A., Armakolas, A., & Koutsilieris, M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802555554 · Cited by 12
“Also, a genetic link exist between autophagy and heart disease, since in Danon disease (where there is genetic deficiency of LAMP2) there was a defective autophagic degradation [82,83] .”
BackgroundLysosome pH Dynamics in Physiology and Disease: Molecular Mechanisms and Therapeutic Insights
Infante-Tadeo, S., & Barber, D. L. (2026) · Acta Physiologica · doi:10.1111/apha.70160 · Cited by 12
“Moreover, our recent analysis of patient-derived iPSCs further supports this conclusion: in models where pHlys is elevated, TMEM175 expression and abundance remain unaltered, indicating that TMEM175 does not correlate with changes in pHlys [42].”
Shalata, A., Bar‐Shai, M., Hadid, Y., Mahroum, M., Mintz, H., Shalata, Z. E., Radzishevsky, E., Genizi, J., Lorber, A., Ben‐Yosef, T., et al. (2023) · Genes · doi:10.3390/genes14081539 · Cited by 11
“Thus, the genetic defect disrupts cytoplasmic trafficking and leads to the accumulation of autophagic material and glycogen in skeletal and cardiac myocytes [2,3].”
BackgroundMethodInfluentialLamp2 inhibits epithelial-mesenchymal transition by suppressing Snail expression in HCC
Zheng, H., YuanYang, Ye, C., Li, P.-P., Wang, Z., Xing, H., Ren, H., & Zhou, W. (2018) · Oncotarget · doi:10.18632/oncotarget.25367 · Cited by 11
Mizushima, N. (2000) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.23.527 · Cited by 11
Wallgren‐Pettersson, C., & Laing, N. G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.017 · Cited by 11
Membrane ion Channels and Receptors in Animal lifespan Modulation
Sheng, Y., Tang, L., Kang, L., & Xiao, R. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25824 · Cited by 11
Majer, F., Piherová, L., Řeboun, M., Stará, V., Pelák, O., Norambuena, P., Stránecký, V., Krebsová, A., Vlášková, H., Dvořáková, L., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40430 · Cited by 11
A novel mouse model of X-linked cardiac hypertrophy
Leatherbury, L., Yu, Q., Chatterjee, B., Walker, D. L., Yu, Z., Tian, X., & Lo, C.-C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00160.2007 · Cited by 11
“Lamp2 has been shown to cause cardiac hypertrophy associated with glycogen accumulation (1, 30, 33).”
BackgroundNew proteins from old diseases provide novel insights in cell biology
Walkley, S. U. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200112000-00020 · Cited by 11
Chaperone-mediated autophagy in fish: A key function amid a changing environment
Schnebert, S., Vélez, E. J., Goguet, M., Dias, K., Véron, V., García-Pérez, I., Radler, L. M., Cardona, E., Fontagné-Dicharry, S., Delft, P. V., et al. (2024) · Autophagy Reports · doi:10.1080/27694127.2024.2403956 · Cited by 10
“LAMP2A, one of the three splice variants (LAMP2A, B and C) of the lamp2 gene, is the only one involved in CMA [9-11].”
Findlay, A. R. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050720 · Cited by 10
“Myopathology is notable for cytoplasmic vacuoles filled with autophagic material and glycogen, and are lined by sarcolemmal proteins (sarcoglycans, dystrophin etc.), leading to their name, AVSF (Endo et al., 2015; Nishino et al., 2000).”
An unusual case of severe myocarditis in a genetic cardiomyopathy: a case report
Popa, M. A., Klingel, K., Hadamitzky, M., Deisenhofer, I., & Hessling, G. (2020) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaa124 · Cited by 10
The physiological determinants of drug-induced lysosomal stress resistance
Woldemichael, T., & Rosania, G. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187627 · Cited by 10
Danon disease: Two patients with atrial fibrillation in a single family and review of the literature
Guo, S., Zhou, L., Wang, R., Lv, Z., Xu, H., Han, B., Korantzopoulos, P. G., Hu, F., & Liu, T. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7777 · Cited by 10
“The LAMP2 c.974delT mutation identified in the cases of the present study is a frameshift mutation in exon 8 of the LAMP2 gene that was first reported by Nishino et al (1).”
BackgroundInfluentialMulder, B. A., Hoedemaekers, Y. M., van den Berg, M. P., van Loon, R. L. E., Wind, A. M., Jongbloed, J. D. H., & Wiesfeld, A. C. P. (2019) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytz132 · Cited by 10
“The gene defect underlying Danon disease causes a deficiency of lysosome-associated membrane protein 2 (LAMP2).(3) In Danon disease, typical cardiac presentation occurs during adolescence and includes left ventricular hypertrophy (LVH) and a Wolff–Parkinson–White pre-excitation pattern on the electrocardiogram (ECG).”
BackgroundTsuda, T., Shillingford, A. J., Vetter, J. M., Kandula, V. V. R., Jain, B., & Temple, J. (2017) · Case Reports in Pediatrics · doi:10.1155/2017/6576382 · Cited by 10
Pepin, M. E., Gong, X., Schulze, A., & Backs, J. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00343-y · Cited by 9
Sun, Y., Wei, J., Ma, S., He, C., Sui, L., Pan, X., & Zhu, X. (2025) · Aging and Disease · doi:10.14336/ad.2025.0275 · Cited by 9
“The merging process of autophagosomes and lysosomes, which is crucial for the degradation of autophagic cargo, is impeded by the absence of lamp2b isoform [255].”
Cardiomyopathies in children: Mitochondrial and storage disease
Norrish, G., & Elliot, P. M. (2018) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2018.08.009 · Cited by 9
Molecular evolution of autophagy rate-limiting factor LAMP2 in placental mammals
Jalali, Z., & Parvaz, N. (2019) · Gene · doi:10.1016/j.gene.2019.144231 · Cited by 9
X-linked Cardiomyopathy Presenting as Contracted Endocardial Fibroelastosis
Sjöberg, G., Chow, C. W., Cooper, S. G., & Weintraub, R. G. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.12.001 · Cited by 9
Cardiac Danon disease: Insights and challenges
Arad, M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.07.106 · Cited by 9
Seo, J., Park, S., Lee, D. C., Yoo, W., Yang, Y. R., Seo, H. W., Park, J. L., Joo, J., Park, K. C., & Byun, S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02688-3 · Cited by 9
Phafins Are More Than Phosphoinositide-Binding Proteins
Tang, T., Hasan, M., & Capelluto, D. G. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098096 · Cited by 8
Genetic Abnormalities of the Sinoatrial Node and Atrioventricular Conduction
Porta‐Sánchez, A., & Priori, S. G. (2023) · Cardiology Clinics · doi:10.1016/j.ccl.2023.03.014 · Cited by 8
Zhang, Q., Chan, W., Chen, Y., Wu, J., Chen, H., Yu, T., Yao, R., Chen, L., Zhang, B., Zhang, H., et al. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.10.005 · Cited by 8
Xie, J., Liu, Y., Wei, X., Ye, W., Ma, Z., Lu, G., Tan, Z., Li, T., Wang, Y., Zhao, L., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.790917 · Cited by 8
“It has been demonstrated that the reduction in LAMP2 protein disrupts intracytoplasmic trafficking, which leads to the accumulation of autophagic materials in myocardial cells (1, 25).”
BackgroundCase Report: Danon Disease: Six Family Members and Literature Review
Wang, Y., Jia, M., Guo, Y., Zhang, T., & Ning, B. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.842282 · Cited by 8
“(4) confirmed mutation of the lysosome-associated membrane 2 (LAMP2) gene (Xq24-q25) and the subsequent loss of LAMP-2 protein in these patients.”
BackgroundBlanco-Arias, P., Martínez, I. M., Fernández, L. A., Rivas, E., Fernández, M. J. S., Hervás, C. G., de Aguilar, P. A. G., Armengol, L., Pedrinaci, S., & Perín, F. (2023) · Neuromuscular Disorders · doi:10.1016/j.nmd.2023.05.008 · Cited by 8
Wang, Y., Bai, M., Zhang, P., Peng, Y., Chen, Z., He, Z., Xu, J., Zhu, Y., Yan, D., Wang, R., et al. (2023) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2216 · Cited by 8
“LAMP2 (Lysosome- associated membrane glycoprotein 2) mutations located on chromosome Xq24 are known to be the major causative gene for DD (Nishino et al., 2000).”
Choi, T. G., & Kim, S. S. (2013) · Hanyang Medical Reviews · doi:10.7599/hmr.2013.33.2.83 · Cited by 8
“심근질환의 하나인 다논병(danon disease)의 경우, 자가포 식소포체와 리소좀의 결합에 관여하는 LAMP-2 단백질의 결핍에 의해 일어난다[40].”
Du, P., Chang, Y., Dai, F., Weı, C., Zhang, Q., & Li, J. (2018) · Gene · doi:10.1016/j.gene.2018.04.042 · Cited by 8
Critoph, C., & Elliot, P. M. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.09.010 · Cited by 8
Pastores, G. M. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_23 · Cited by 8
Chen, C., Hsu, H., & Chen, M.-F. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214542071 · Cited by 8
“Several studies have reported that cardiac hypertrophy is associated with a change in autophagy.(10,11) To examine whether autophagy was changed by Ang II treatment, H9C2 cells were treated with 1 or 20 mM Ang II for 24 h and then were incubated for 24 h in serum-free medium for starvation stress or with 100mM H2O2 fo…”
MethodVMA21 Deficiency: A Case of Myocyte Indigestion
Hirano, M., & DiMauro, S. (2009) · Cell · doi:10.1016/j.cell.2009.04.005 · Cited by 8
“…a drug for treating malaria and rheumatoid arthritis, and Danon disease, an X-linked dominant myopathy due to LAMP2 deficiency, cause skeletal myopathies that closely resemble XMEA (although brain and heart are also clinically affected in Danon disease) (Kalimo et al., 1988; Nishino et al., 2000).”
BackgroundSelf-citationA decline of LAMP- 2 predicts ursodeoxycholic acid response in primary biliary cirrhosis
Wang, L., Guo, G., Wang, J., Zhou, X., Yang, Q., Han, Z.-Y., Li, Q., Zhang, J., Cai, Y., Ren, X., et al. (2015) · Scientific Reports · doi:10.1038/srep09772 · Cited by 8
Cardiovascular involvement in glycogen storage diseases
Pinós, T., Cubbon, R. M., Santalla, A., Fiuza‐Luces, C., Santos‐Lozano, A., Martín, M. A., Arenas, J., Nielsen, J., Ørtenblad, N., & Lucía, A. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01171-w · Cited by 7
“However, in 2000, variants in LAMP2 , encoding the lysosome-associated membrane glycoprotein 2 (LAMP2), were identified as the cause of Danon disease 191 — the first example of a human cardiomyopathy syndrome caused by alterations in a lysosomal structural protein rather than an enzyme 191 .”
Abouward, R., Abdelhafid, A. M., Wilkins, O. G., Lee, S.-Y., Ibrahim, F., Skehel, M., Ting, A. Y., Birsa, N., Ule, J., & Schiavo, G. (2026) · Journal of Cell Science · doi:10.1242/jcs.264466 · Cited by 7
“Consistent with this, variants in human LAMP2 cause Danon ’ s disease, a lysosomal storage disorder characterised by fatal cardiomyopathy, vacuolar myopathy and cognitive impairments (Nishino et al., 2000).”
Autophagy in striated muscle diseases
Bailin, P. L., Zhang, L., Zhang, L., & Han, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1000067 · Cited by 7
Mechanisms of DNA Damage Response in Mammalian Oocytes
Sun, F., Šutovský, P., Patterson, A. L., & Balboula, A. Z. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-55163-5_3 · Cited by 7
Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement
Burban, A., Pucyło, S., Sikora, A., Opolski, G., Grabowski, M., & Kołodzińska, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713239 · Cited by 7
DANON DISEASE: A RARE SYSTEMIC DISORDER WITH THE LAMP2-CARDIOMYOPATHY
Vaikhanskaya, T. G., Sivitskaya, L. N., Даниленко, Н. Г., Sidorenko, I. V., & Davydenko, O. G. (2017) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2017-10-93-99 · Cited by 7
Danon disease: A novel mutation in the LAMP-2 gene and ophthalmic abnormality
He, J., Wang, Y., & Jiang, T. (2013) · Herz · doi:10.1007/s00059-013-3900-5 · Cited by 7
Myo-Glyco disease Biology: Genetic Myopathies Caused by Abnormal Glycan Synthesis and Degradation
Kanagawa, M. (2019) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180369 · Cited by 7
“Not only lysosomal enzymes, but also defects in lysosomal structural proteins can cause LSDs, such as Danon disease [56].”
BackgroundSuzuki, K., & Suzuki, K. (2008) · CRC Press eBooks · doi:10.1201/b13319-8 · Cited by 7
Seale, B. C., Slotabec, L. A., Nguyen, J. D., Wang, H., Patterson, C., Filho, F., Rouhi, N., Adenawoola, M. I., & Li, J. (2024) · The FASEB Journal · doi:10.1096/fj.202401404r · Cited by 6
Sex‐Specific Cardiac Magnetic Resonance Phenotypes in Danon Disease: A Retrospective Cohort Study
Liu, N., Yang, K., Cao, G., Chen, Z., Yin, G., Dong, W., Wang, X., Li, J., & Lu, M. (2025) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.70102 · Cited by 6
Lehman, M. B., Orgil, B., Guerrier, K., Hirono, K., Batsaikhan, E., Saito, K., Collyer, J. W., Towbin, J. A., & Purevjav, E. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm39044 · Cited by 6
Danon disease: Two case reports and literature review
Yu, K., Peng, B., Zhao, D., & Wang, Y. (2026) · Medicine · doi:10.1097/md.0000000000046993 · Cited by 6
“[15] Additionally, in female patients with DD, the detection of LAMP2 protein reveals a mosaic distribution of LAMP2 positive and negative muscle fibers.”
Sun, Y., Lv, Q., Chen, D., Da, Y., Zhao, X., & Dong, J. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s392800 · Cited by 6
“Introduction Danon disease is an X-chromosome-linked dominant disorder caused by mutations in the lysosome-associated membrane protein 2 (LAMP2) gene.(1) The typical symptoms are cardiomyopathy, skeletal myopathy, and intellectual disability.”
BackgroundHeart transplantation in Danon disease: A single family displaying diverse phenotypes
Poignant, S., Bourguignon, T., & Espitalier, F. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.10.027 · Cited by 6
Codron, P., Pautot, V., TASSIN, A., Sternberg, D., Letournel, F., Richard, P., & Nadaj‐Pakleza, A. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.04.012 · Cited by 6
Li, Y., Zhao, K., Zong, P., Fu, H., Zheng, Y., Bao, D., Yin, Y., Chen, Q., Lu, L., Dai, Y., et al. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10199 · Cited by 6
Sun, Y., Liu, S., & Sun, L. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.734980 · Cited by 6
Fernandez, C., de Paula, A. M., Figarella‐Branger, D., & Pellissier, J. (2010) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(10)53771-0 · Cited by 6
“Cette affection de transmission autosomique dominante liée à l’X est due à des mutations dans le gène LAMP2 [71].”
BackgroundCzaja, A. J. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08118-6 · Cited by 6
“Danon disease is characterized by the accumulation of intracytoplasmic vacuoles containing diverse substrates and glycogen in skeletal and cardiac myocytes [200, 201].”
BackgroundTerasawa, K., Seike, T., Sakamoto, K., Ohtake, K., Terada, T., Iwata, T., Watabe, T., Yokoyama, S., & Hara‐Yokoyama, M. (2023) · Protein Science · doi:10.1002/pro.4823 · Cited by 6
“LAMP2B is highly expressed in human cardiomyocytes, where its deficiency impairs the autop-hagosome-lysosome fusion to cause the cardiomyopathy in Danon disease (Chi et al., 2019; Nishino et al., 2000).”
BackgroundTemas de actualidad en insuficiencia cardiaca
Colet, J. C., Aguilera, R. M., Castillo, J. J. C., & Delgado, J. F. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70044-2 · Cited by 6
Wierzba‐Bobrowicz, T., Lewandowska, E., Ługowska, A., Rola, R., Stępień, T., Ryglewicz, D., & Pasennik, E. (2007) · PubMed · Cited by 6
Sánchez‐Lanzas, R., Alvarez‐Castelao, B., Bermejo, T., Ayuso, T., Tuñón, T., & Castaño, J. G. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.014 · Cited by 6
Lysosomes and Nanotherapeutics: Diseases, Treatments, and Side Effects
Manthe, R. L., & Muro, S. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0025 · Cited by 6
Case Report: A Novel LAMP2 Splice-Altering Mutation Causes Cardiac-Only Danon Disease
Li, Z., Ma, F., Li, R., Xiao, Z., Zeng, H., & Wang, D. W. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.763240 · Cited by 6
“Some of these mutations cause symptoms involving only the heart (1, 15), while other mutations also cause clinical manifestations of multi-organ damage including cardiac hypertrophy, mental retardation, and musculoskeletal defects (2, 13, 14).”
BackgroundEndocytic Trafficking and Human Diseases
Puertollano, R. (2008) · Springer eBooks · doi:10.1007/978-0-387-39951-5_10 · Cited by 6
Ocular Manifestations of Inborn Errors of Metabolism
Ganesh, A., Al-Murshedi, F., Al-Zuhaibi, S. S., & Al‐Thihli, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-18389-3_13 · Cited by 6
Genetics in cardiovascular diseases
Celeghin, R., Thiene, G., Bauce, B., Basso, C., & Pilichou, K. (2019) · Italian Journal of Medicine · doi:10.4081/itjm.2019.1186 · Cited by 6
Autophagic vacuolar myopathy: Danon disease and related myopathies
Sugie, K. (2021) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12554 · Cited by 6
Critical role of miR-21/exosomal miR-21 in autophagy pathway
Saadh, M. J., Mahdi, M. S., Allela, O. Q. B., Alazzawi, T. S., Ubaid, M., Rakhimov, N., Athab, Z. H., Ramaiah, P., Chinnasamy, L., Alsaikhan, F., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155275 · Cited by 5
Repeat Expansions in PLIN4 Cause Autosomal Dominant Vacuolar Myopathy With Sarcolemmal Features
Llansó, L., Stevanovski, I., Morís, G., Collet‐Vidiella, R., Segarra‐Casas, A., González‐Quereda, L., Rodríguez‐Santiago, B., Gallano, P., Álvarez‐Velasco, R., Vesperinas, A., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70146 · Cited by 5
Case Report: Identification of Mutations in LAMP2 in Two Chinese Infants With Danon Disease
Zhang, L., Yang, F., Chen, M., Zhou, M. D., Qian, T., Mujtaba, M. O., Mohammed, A. H., Yin, J., Cheng, X., Chen, J., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.589838 · Cited by 5
Sun, C., Zhang, N., Hu, Q., & Xia, G. (2023) · Disease Markers · doi:10.1155/2023/8295113 · Cited by 5
“Deficiency of lysosomal membrane proteins has been shown to cause clinical manifestations ranging from severe visceral symptoms to neurodegeneration, and a classic example associated with null mutation of LAMP2 is Danon disease [19].”
BackgroundYamaguchi, F., Sakane, H., & Akasaki, K. (2023) · The Journal of Biochemistry · doi:10.1093/jb/mvad096 · Cited by 5
Ceasovschih, A., Balta, A., Șorodoc, V., Rathod, K. S., Gohary, A. E., Covanţev, S., Masszi, R., Şener, Y. Z., Corlăteanu, A., Naqvi, S. H. R., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15121568 · Cited by 5
“In 2000, Ichizo Nishino et al. identified the underlying cause as a mutation in a lysosomal membrane protein (LAMP2), rather than a lysosomal enzyme, clarifying the pathophysiology of the disorder [121].”
How to effectively utilize genetic testing in the care of children with cardiomyopathies
Russell, M. W. W., Roberts, A. E., Abrams, D. J., Murphy, A. M., Towbin, J. A., & Chung, W. K. (2015) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2015.01.001 · Cited by 5
“Danon disease is an X-linked disorder due to a defect in the lysosome-associatedmembrane protein LAMP2 [16] and is most appropriately characterized as a vacuolar or lysosomal disorder [17].”
BackgroundProgression of Danon disease with medical imaging: two case reports
Wang, S., Wang, Q., Zhai, N., Wang, X., Li, Z., Gan, L., & Cui, Y. (2021) · Journal of International Medical Research · doi:10.1177/0300060520986676 · Cited by 5
Pacemaker Malfunctions in Danon's Disease
Marras, E., Sciarra, L., Bocchino, M., & Delise, P. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00937.x · Cited by 5
Metadata
- Authors
- Nishino, I., Fu, J., Tanji, K., Yamada, T., Shimojo, S., Koori, T., Mora, M., Riggs, J. E., Oh, S. J., Koga, Y., Sue, C. M., Yamamoto, A., Murakami, N., Shanske, S., Byrne, E., Bonilla, E., Nonaka, I., DiMauro, S., & Hirano, M.
- Affiliations
- Columbia University (US)
- Kyushu University (JP)
- St. Marianna University School of Medicine (JP)
- Yokohama Rosai Hospital (JP)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- West Virginia University (US)
- University of Alabama at Birmingham (US)
- Kurume University (JP)
- National Center of Neurology and Psychiatry (JP)
- St Vincent's Hospital Melbourne (AU)
- Corresponding author
- Nishino, Ichizo
- ORCID
- Venue
- Nature
- Published
- 2000-08
- Volume
- 406
- Issue
- 6798
- Pages
- 906-910
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2109716633
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 30 · 2023: 44 · 2022: 35 · 2021: 44 · 2020: 45 · 2019: 46 · 2018: 57 · 2017: 45 · 2016: 62 · 2015: 44 · 2014: 40 · 2013: 51 · 2012: 45
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Danon disease, lysosomal membrane proteins, lysosomal storage disease, cardiomyopathy, myopathy, intracytoplasmic vacuoles, glycogen storage disease
- MeSH terms
- DNA Mutational Analysis, Female, Humans, Immunohistochemistry, Genetic Linkage, Male, Membrane Glycoproteins, Molecular Sequence Data, Muscular Diseases, Cardiomyopathies, Vacuoles, X Chromosome, Blotting, Western, Antigens, CD, Lysosomal Storage Diseases, Sequence Analysis, DNA, Muscle, Skeletal, Lysosomal Membrane Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.